Skip to Main Content

David Fiellin, MD

Professor of Medicine (General Medicine), of Emergency Medicine, and of Public Health; Vice Chief of Faculty Affairs, General Internal Medicine; Director, Program in Addiction Medicine

Contact Information

David Fiellin, MD

Office Location

Research Summary

Dr. Fiellin has focused his scholarly work on the interface between primary care and substance abuse. He conducts research on the transfer of treatment strategies, including opioid agonist treatment with buprenorphine and alcohol pharmacotherapies, from specialized settings to office-based, primary care, emergency department and HIV specialty settings.

Specialized Terms: Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol


Research Interests

Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Opioid-Related Disorders; Public Health; Substance Withdrawal Syndrome; Tobacco Use Disorder; Substance Abuse Detection; Substance Abuse Treatment Centers; Clinical Trial; Multicenter Study; Meta-Analysis; Health Care Quality, Access, and Evaluation; Cocaine-Related Disorders; Alcohol-Related Disorders; Drug Overdose; Observational Study; Addiction Medicine; Marijuana Use; Implementation Science; Systematic Review

Selected Publications

Clinical Trials

ConditionsStudy Title
Addictive Behaviors; Mental Health & Behavioral ResearchSupport Models for Addiction Related Treatment (SMART) Trial of Opioid Use Disorder in Pregnant Women
Addictive Behaviors; Alcohol Addiction; Mental Health & Behavioral ResearchPrazosin for Alcohol Use Disorder